We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDR:LSESchroders PLC Analysis

Data as of 2026-08-21 - not real-time

£583.50

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At £583.50, Schroders plc shows no decisive moving-average alignment, leaving the trend neutral. RSI sits at 41.8, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near £578.50 and resistance around £591.00.
On valuation the read is fair — earnings multiple of 13.3 versus a 16.7 sector average, below the peer group. Sell-side targets cluster 7.0% below the current quote. Revenue is growing at 15.6% on a 19.1% profit margin. The 3.77% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 3.0%, a beta of -0.11 and a maximum drawdown of 8.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top Market Events

Schroders stock held at 584.0 GBX as of August 20, 2026, after the asset manager reported higher firLondon South East15dForm 8.5 EPT/NON-RI -Schroders plcAll interests and all short positions should be disclosed....London South East1monHolding s in Company20th Aug 2026 11:50 am RNS Form 8.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 524.15
  • MACD momentum is negative
  • RSI at 41.8 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 13.3 versus sector average of 16.7
  • Trading above the 200-day average of 524.15
  • Analyst targets imply -7.0% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 13.3 versus sector average of 16.7
  • Analyst targets imply -7.0% versus the current price
  • Profit margin of 19.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth15.60%
Profit Margin19.13%
P/E Ratio13.3
ROE15.76%
ROA2.51%
Debt/Equity12.59
P/B Ratio2.0
Op. Cash Flow£-112300000
Free Cash Flow£619.6M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI41.8
Support£578.50
Resistance£591.00
MA 20£586.05
MA 50£586.08
MA 200£524.15
MACDBearish
VolumeIncreasing
Fear & Greed Index92.84

Valuation

Fair Value£1,276.49
Target Price£542.41
Upside/Downside-7.04%
GradeFair
TypeBlend
Dividend Yield3.77%

Risk Assessment

Beta-0.11
Volatility3.02%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.